Matching-adjusted indirect treatment comparison of [177Lu]Lu-DOTA-TATE, everolimus and sunitinib in advanced, unresectable gastroenteropancreatic neuroendocrine tumours: Relative effectiveness of [177Lu]Lu-DOTA-TATE in gastroenteropancreatic neuroendocrine tumours

European Journal of Cancer: Supplement · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles